Anticancer Attributes of Cantharidin: Involved Molecular Mechanisms and Pathways

Faiza Naz,Yixin Wu,Nan Zhang,Zhao Yang,Changyuan Yu

DOI: https://doi.org/10.3390/molecules25143279

IF: 4.6

2020-07-19

Molecules

Abstract:Cancer is a preeminent threat to the human race, causing millions of deaths each year on the Earth. Traditionally, natural compounds are deemed promising agents for cancer treatment. Cantharidin (CTD)—a terpenoid isolated from blister beetles—has been used extensively in traditional Chinese medicines for healing various maladies and cancer. CTD has been proven to be protein phosphatase 2A (PP2A) and heat shock transcription factor 1 (HSF-1) inhibitor, which can be potential targets for its anticancer activity. Albeit, it harbors some toxicities, its immense anticancer potential cannot be overlooked, as the cancer-specific delivery of CTD could help to rescue its lethal effects. Furthermore, several derivatives have been designed to weaken its toxicity. In light of extensive research, the antitumor activity of CTD is evident in both in vitro as well as in vivo cancer models. CTD has also proven efficacious in combination with chemotherapy and radiotherapy and it can also target some drug-resistant cancer cells. This mini-review endeavors to interpret and summarize recent information about CTD anticancer potential and underlying molecular mechanisms. The pertinent anticancer strength of CTD could be employed to develop an effective anticarcinogenic drug.

chemistry, multidisciplinary,biochemistry & molecular biology

What problem does this paper attempt to address?

The paper attempts to address the issue of exploring the anticancer properties of cantharidin (CTD) and the molecular mechanisms behind it. Specifically:

1. **Anticancer Potential**: The paper emphasizes the anticancer effects of cantharidin in various cancer models, including both in vitro and in vivo experiments. Studies have shown that cantharidin can inhibit various types of cancer cells, such as liver cancer, pancreatic cancer, colon cancer, bladder cancer, and breast cancer.

2. **Molecular Mechanisms**: The paper delves into the specific molecular mechanisms of cantharidin's anticancer effects. Cantharidin exerts its anticancer action by inhibiting protein phosphatase 1 (PP1) and protein phosphatase 2A (PP2A), and it can also reduce the expression levels of HSP70 and BAG3 proteins by preventing heat shock transcription factor 1 (HSF-1) from binding to promoters.

3. **Toxicity Issues**: Although cantharidin has significant anticancer effects, it also has certain toxicity. To overcome this issue, researchers have designed many derivatives to mitigate its toxicity. For example, ethanolamine can serve as an effective detoxifying agent to alleviate the cytotoxicity of cantharidin.

4. **Comprehensive Application**: The paper also discusses the potential of combining cantharidin with other treatment methods (such as chemotherapy and radiotherapy) and points out that cantharidin can target certain drug-resistant cancer cells.

In summary, this paper aims to comprehensively summarize the anticancer effects of cantharidin and its potential molecular mechanisms, providing a theoretical basis for the development of new anticancer drugs.